Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-27

Clinical Trial Update: Ziprasidone in the Psychosis Prodrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for ziprasidone in the psychosis prodrome; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ziprasidone (ziprasidone)

Snippet

Sponsor: Yale University | Conditions: Psychosis Prodrome | Phase 2 | Status: COMPLETED | Results posted: 2016-10-27